News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Innophos Holdings, Inc. Declares Dividend of $0.35 Per Share; Increases Rate by 30%



11/5/2012 12:38:23 PM

CRANBURY, N.J., Nov. 5, 2012 /PRNewswire/ -- Innophos Holdings, Inc. (NASDAQ: "IPHS") today confirmed the details of the recently announced increase of the quarterly dividend to $0.35 per share of common stock declared by its Board of Directors. The dividend will be payable on November 30, 2012 to stockholders of record as of the close of business on November 16, 2012. The new rate represents a 30% increase over the previous $0.27 per share quarterly dividend rate.

Randy Gress, Chief Executive Officer and Chairman of the Board, commented, "I remain highly confident in the strength of our earnings and cashflow generation and in our prospects for future growth. Our capital allocation priorities continue to be investing to support organic growth, strengthening our product portfolio and market position through complementary, bolt-on acquisitions and improving cash returns to shareholders. We have made significant progress on all fronts over the last 12 months, and I am pleased with the decision by our Board of Directors to increase our quarterly dividend by 30% to $0.35 per share. This increase, our third in less than two years, means we have more than doubled our dividend since 2010."

About Innophos Holdings, Inc.
Innophos is a leading international producer of performance-critical and nutritional specialty ingredients, with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. Innophos combines more than a century of experience in specialty phosphate manufacturing with a growing capability in a broad range of other mineral ingredients to supply a product range produced to stringent regulatory manufacturing standards and the quality demanded by customers worldwide. Innophos is continually developing new and innovative specialty ingredients addressing specific customer applications and supports these high-value products with industry-leading technical service. Headquartered in Cranbury, New Jersey, Innophos has manufacturing operations in Nashville, TN; Chicago Heights, IL; Chicago (Waterway), IL; Geismar, LA; Ogden, UT; North Salt Lake, UT; Port Maitland, ON (Canada); and Coatzacoalcos, Veracruz and San Jose de Iturbide (Mission Hills), Guanajuato (Mexico). For more information please visit www.innophos.com. 'IPHS-G'

Contact Information:


Innophos Holdings, Inc.

FTI Consulting, Inc.

Investor Relations: (609) 366-1299

Alexandra Tramont/Matt Steinberg

investor.relations@innophos.com

212-850-5600

SOURCE Innophos Holdings, Inc.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES